Innovative first in class HSF1 pathway cancer drug shows strong results in new study 05 Apr 2023 A new, oral ‘first in class’ experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows. Find out more Show/Hide